Suppr超能文献

中国/亚洲口咽鳞状细胞癌人群中HPV与p16不一致组合的预后分析

Prognostic analysis of inconsistent combinations of HPV and p16 in a Chinese/Asian oropharyngeal squamous cell carcinoma population.

作者信息

Li Jieying, Zhou Kai, Zhan Xiaohong, Lu Haijun, Hao Dapeng, Song Kai, Wang Shuangyi, Feng Yuanyong, Xu Haoyue, He Zongxuan, Yang Xiaochen, Shang Wei, Wang Lin

机构信息

Department of Oral & Maxillofacial Surgery, the Affiliated Hospital of Qingdao University, 16 Jiangsu Road, Qingdao, Shandong Province, 266000, China.

School of Stomatology, Qingdao University, Qingdao, Shandong Province, 266000, China.

出版信息

Infect Agent Cancer. 2025 Jun 9;20(1):35. doi: 10.1186/s13027-025-00657-z.

Abstract

BACKGROUND

The aim of this study was to investigate the effect of inconsistent expression of p16 and HPV on the prognosis of patients with Oropharyngeal squamous cell carcinoma (OPSCC) in Chinese/Asian populations.

METHODS

The study included 130 patients. Inclusion criteria were primary OPSCC. The primary outcome was the proportion of cohort patients showing different combinations of p16 and HPV outcomes, as well as overall survival (OS) and progression-free survival (PFS). Patients with relapsed or metastatic disease or palliative care were excluded from the survival analysis. A multivariate analysis model was used to calculate the adjusted hazard ratio for overall survival for different p16 and HPV tests, adjusted for pre-specified confounders.

RESULTS

Among the 130 patients, 25 (19.2%) demonstrated inconsistency between HPV and p16 expressions. The inconsistency in HPV/p16 status was significantly associated with patient age, smoking history, and alcohol consumption, leading to significant differences in tumor site, TNM staging, and differentiation, thereby influencing treatment decisions. There were significant differences in OS (P = 0.04) and PFS (P = 0.011) among the three groups, with the inconsistent group falling between the HPV+/p16 + group and the HPV-/p16- group but closer to the latter. Out of 54 p16-positive patients, only 33 (61.1%) were HPV-positive, indicating a lower predictive value of p16 for HPV positivity in OPSCC than observed in Western populations. Moreover, the study suggested a potential positive correlation between p16 expression intensity and improved patient prognosis.

CONCLUSION

In the China/Asia region, where HPV infection rates are relatively low, the predictive power of p16 for HPV-related OPSCC is low. We recommend additional HPV testing in patients with p16 + OPSCC to improve diagnostic accuracy, thereby enabling the selection of the best de-escalation treatment strategy, increasing treatment response rates, and ultimately improving the overall prognosis in these patients.

摘要

背景

本研究旨在探讨中国/亚洲人群中p16和人乳头瘤病毒(HPV)表达不一致对口咽鳞状细胞癌(OPSCC)患者预后的影响。

方法

该研究纳入了130例患者。纳入标准为原发性OPSCC。主要结局是队列患者中显示p16和HPV检测结果不同组合的比例,以及总生存期(OS)和无进展生存期(PFS)。复发或转移性疾病患者或接受姑息治疗的患者被排除在生存分析之外。使用多变量分析模型计算不同p16和HPV检测的总生存期调整风险比,并对预先指定的混杂因素进行调整。

结果

在130例患者中,25例(19.2%)显示HPV和p16表达不一致。HPV/p16状态的不一致与患者年龄、吸烟史和饮酒显著相关,导致肿瘤部位、TNM分期和分化存在显著差异,从而影响治疗决策。三组之间的OS(P = 0.04)和PFS(P = 0.011)存在显著差异,不一致组介于HPV+/p16+组和HPV-/p16-组之间,但更接近后者。在54例p16阳性患者中,只有33例(61.1%)为HPV阳性,表明OPSCC中p16对HPV阳性的预测价值低于西方人群。此外,该研究表明p16表达强度与患者预后改善之间可能存在正相关。

结论

在中国/亚洲地区,HPV感染率相对较低,p16对HPV相关OPSCC的预测能力较低。我们建议对p16+的OPSCC患者进行额外的HPV检测,以提高诊断准确性,从而能够选择最佳的降阶梯治疗策略,提高治疗反应率,并最终改善这些患者的总体预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0305/12150553/404ad55182a9/13027_2025_657_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验